Clinical trials
Recruiting Phase 2 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Great Novel Therapeutics Biotech & Medicals Corporation | 1 |
| Jonathan Brammer | 1 |
| Liling Zhang | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Cancer Centre, Singapore | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Seda S. Tolu | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 15 |
| Lymphoma, T-Cell | 3 |
| Lymphoma, T-Cell, Cutaneous | 3 |
| Lymphoma | 2 |
| Recurrence | 2 |
| Graft vs Host Disease | 1 |
| Leukemia | 1 |
| Leukemia, Prolymphocytic, T-Cell | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.